In the last decade, advances in molecular techniques have demonstrated recurrent genetic alterations in some salivary gland tumors, including the fusion of genes such as ETV6 in secretory carcinoma, MYB and MYBL1 in adenoid cystic carcinoma, and MAML2 in MEC (26–28). Here, MAML2 is linked to adenoid cystic carcinoma.